OUTFRONT Media vs Regency Centers
OUT and REG side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How OUT and REG compare
Regency Centers is the larger company, worth 2.4 times as much as OUTFRONT Media ($14.0B against $5.9B).
OUTFRONT Media grew revenue faster over the last twelve months (9.1% versus 8.2% for Regency Centers).
Regency Centers keeps more of each dollar of sales as profit, with a net margin of 34.4% compared with 13.1% at OUTFRONT Media.
Both pay dividends: OUTFRONT Media yields 3.7% and Regency Centers 4.0%.
Regency Centers scores higher on the StockData Score (14 against 9 for OUTFRONT Media), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | OUT | REG |
|---|---|---|
| Size and price | ||
| Market cap | $5.9B | $14.0B |
| Share price | $33.67 | $76.18 |
| Change, 1 year | 66.9% | 8.7% |
| Change, 5 years | 20.9% | 3.2% |
| Beta (5Y) | 1.48 | 0.66 |
| Employees | 1,986 | 507 |
| StockData Score | ||
| Total score | 9 | 14 (better) |
| Valuation score | 1 | 1 |
| Growth score | 1 | 1 |
| Performance score | 4 | 5 (better) |
| Health score | 0 | 4 (better) |
| Dividend score | 3 | 3 |
| Valuation | ||
| P/E | 23.1× | – |
| P/S | 3.0× (better) | 8.6× |
| P/B | 8.4× | 2.0× (better) |
| EV/EBITDA | 15.0× | 8.8× (better) |
| P/FCF | 17.2× | – |
| FCF yield | 5.8% | – |
| Fair value | $25.84 | $70.22 |
| Margin of safety | −30.3% | −8.5% (better) |
| Growth | ||
| Revenue growth (TTM) | 9.1% (better) | 8.2% |
| Revenue growth, 5Y average | 8.2% | 8.9% (better) |
| Net income growth (TTM) | 108% (better) | 37.8% |
| EPS growth (TTM) | 115% | – |
| Profitability | ||
| Operating margin | 20.7% | 72.0% (better) |
| Net margin | 13.1% | 34.4% (better) |
| FCF margin | 17.4% | – |
| Return on equity | 41.4% (better) | 8.2% |
| Return on invested capital | 13.0% | 13.9% (better) |
| Financial health | ||
| Debt / equity | 3.59 (better) | 0.00 |
| Net debt / EBITDA | 4.39 | – |
| Current ratio | 0.72 | – |
| Altman Z-score | 0.86 | 1.82 (better) |
| Piotroski F-score | 6 | – |
| Dividends and buybacks | ||
| Dividend yield | 3.7% | 4.0% (better) |
| Payout ratio | 84.0% | 95.7% |
| Years of dividend growth | 0 | 12 (better) |
| Dividend growth, 5Y average | 25.9% (better) | 3.8% |
| Shareholder yield | 3.7% | 4.0% (better) |
| Ownership | ||
| Held by institutions | 104% | 101% |
| Held by insiders | 15.8% | 0.52% |
| Insider net buying, 12 months | −$4.3M (better) | −$39.9M |
| Superinvestors holding | 1 | 1 |
| Short interest, % of float | 5.2% | – |
Go deeper
- OUT stock overview
- OUT income statement
- OUT valuation and score
- REG stock overview
- REG income statement
- REG valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.